Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Multiple Myeloma × aflibercept × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 25 Neoplasm Metastasis 15 Neoplasms 13 Rectal Neoplasms 8 Colorectal Cancer Metastatic 7 Colonic Neoplasms 6 Ovarian Neoplasms 5 Lymphoma, Non-Hodgkin 5 Uveal Melanoma 4 Sarcoma 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Melanoma 4 Lymphoma, Mantle-Cell 4 Lymphoma, Large-Cell, Immunoblastic 4 Lymphoma, Large B-Cell, Diffuse 4 Lymphoma, Follicular 4 Lymphoma, B-Cell, Marginal Zone 4 Leukemia, Lymphocytic, Chronic, B-Cell 4 Fallopian Tube Neoplasms 4 Carcinoma, Ovarian Epithelial 4 Burkitt Lymphoma 4 Uterine Cervical Neoplasms 3 Urinary Bladder Neoplasms 3 Urethral Neoplasms 3 Stomach Neoplasms 3 Prostatic Neoplasms 3 Lung Neoplasms 3 Glioblastoma 3 Endometrial Neoplasms 3 Carcinoma, Renal Cell 3

Interventions

Dexamethasone 801 Bortezomib 442 Lenalidomide 429 Cyclophosphamide 335 Melphalan 249 Calcium Dobesilate 236 daratumumab 216 pomalidomide 197 carfilzomib 180 fludarabine phosphate 130 Thalidomide 121 fludarabine 118 Peripheral Blood Stem Cell Transplantation 117 Filgrastim 111 ixazomib 85 Mycophenolic Acid 85 Granulocyte Colony-Stimulating Factor 84 Busulfan 83 Whole-Body Irradiation 80 Tacrolimus 75 dexamethasone acetate 74 Cyclosporine 67 Prednisone 64 dexamethasone 21-phosphate 63 isatuximab 60 elotuzumab 59 auricularum 57 Antilymphocyte Serum 55 belantamab mafodotin 53 Etoposide 52

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00437034 2021-02-08

Aflibercept for Relapsed Multiple Myeloma

National Cancer Institute (NCI)

Phase 2 Terminated

6 enrolled 5 charts

Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡